Wider Reach, Stronger Studies
Our extensive network of engaged patients assures you of access to hard-to-reach populations affected by genetic disorders. We strategically recruit the most eligible participants and increase study retention by taking biospecimen and data collection directly to the patient’s home. As a fully integrated services solution, you can expect streamlined logistics that allow you to focus on advancing the next therapy instead.
- Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- Cystic Fibrosis (CF)
- Down Syndrome (Trisomy 21)
- Duchenne Muscular Dystrophy (DMD)
- Glucose-6-phosphate-dehydrogenase (G6PD)
- Hereditary Hemorrhagic Telangiectasia (HHT)
- Hunter’s Syndrome (MPS II)
- Huntington's Disease (HD)
- Myotonic Dystrophy
- Spinal Muscular Atrophy
Sanguine's Expertise in Genetic & Rare Diseases
>800
Patient Members
>25
Studies Completed
Sanguine Services
- Whole Blood
- Serum/Plasma
- Urine (Ex: Lupus nephritis)
- Noninvasive Skin Tapes (ex: Atopic dermatitis)
- DNA/RNA
- PBMCs (+ Derivatives)
- Hair
- Stool
- Semen
- Nails
- Buffy Coat
- PBMC isolation
- "Treatment naive (eg: no disease-modifying therapies)"
- Identify specific mutations and genotypes
- Enzyme deficiency
- Familial history
- Disease Confirmation
- Covid-19 (PCR)
- Sickle Cell
- HIV/HPV/Hepatitis/Herpes Etc.
- BioMarker Quantification
- CBC, Platelett, & Diff
- CRP
- Cal-Protecin
- ANA
- Cytokine Panel
- BUN
- Urinalysis
- Thyroid Stimulating Hormone
- Lipid Panel
- LDH
- Genetic Analysis
- HLA Typing
- dsDNA
- RNA Vial Load Qaunitification
- HBV Genotyping
- Single Timepoint - Huntingtons
- Ability to consent and enroll pediatric patients
- Connect with hard to reach patients / rare disease patients
- Access to patients via patient advocacy groups and non-profit organizations
